Evidence map›Paper›PMID 41174245›Full record

ArticleAnalytical and bioanalytical chemistry2025

GPBD: high-confidence N-glycopeptide identification via glycopeptide boundary discriminator.

Qiudi Ye, Xiguo Yuan, Shisheng Sun, Xue Li

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qiudi YeSchool of Computer Science and Technology, Xidian University, Xi'an, 710071, P. R. China.
Xiguo YuanHangzhou Institute of Technology, Xidian University, Hangzhou, 311231, P. R. China.
Shisheng SunLaboratory for Disease Glycoproteomics, College of Life Sciences, Northwest University, Xi'an, 710069, P. R. China.
Xue LiHangzhou Institute of Technology, Xidian University, Hangzhou, 311231, P. R. China. lixue02@xidian.edu.cn.

Funding

National Key Research and Development Program of China 2019YFA0905200National Natural Science Foundation of China 22374117Natural Science Foundation of Shaanxi Province 2023-JC-ZD-46Natural Science Foundation of Shaanxi Province 2024JC-TBZC-06Shaanxi Fundamental Science Research Project for Chemistry and Biology 23JHZ006
6 · The paper itself

Abstract

Accurate identification of both glycan and peptide components is critical for mass spectrometry-based glycoproteomics, yet high-confidence glycan spectrum matches (GSMs) are often discarded during quality control due to low-confidence peptide spectrum matches (PSMs). To address this, we developed the glycopeptide boundary discriminator (GPBD), a new methodology that integrates glycan and peptide information to precisely define the glycan-peptide boundary. The GPBD framework consists of three main steps, for each spectrum: (1) enumerating several possible peptide masses from the core Y-ion ladder (low-energy scan) and then uses b/y evidence in the high-energy scan to rank peptide candidates, (2) for each candidate, matching a series of glycan ions to build a glycan ion pattern (GIP), (3) a classifier discriminates GIPs of the top candidates to finalize peptide assignment. This method is integrated into StrucGP, our previously developed software for N-glycopeptide identification. Experiments using GPBD on mouse brain and sperm datasets demonstrated an increase in glycopeptide spectra matches (GPSMs) due to more accurate peptide identification, while simultaneously maintaining high confidence in glycan identification. Furthermore, analysis of fetuin datasets showed GPBD's potential usage in database-independent peptide identification pipeline.

Indexed as

GlycopeptidesProteomicsAnimalsBrain ChemistryMaleMicePolysaccharidesSoftwareSpermatozoaTandem Mass SpectrometryGlycopeptidesPolysaccharidesGlycoproteomicsMachine learningMass spectrometryN-Glycopeptide identification

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.